These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15363462

  • 1. Variations in "rescuability" of immunoglobulin molecules from different forms of human lymphoma: implications for anti-idiotype vaccine development.
    Rodríguez-Calvillo M, Inogés S, López-Díaz de Cerio A, Zabalegui N, Villanueva H, Bendandi M.
    Crit Rev Oncol Hematol; 2004 Oct; 52(1):1-7. PubMed ID: 15363462
    [Abstract] [Full Text] [Related]

  • 2. Feasibility of idiotype vaccination in relapsed B-cell malignancies.
    Inogés S, Rodríguez-Calvillo M, López-Díaz de Cerio A, Zabalegui N, Pérez-Calvo J, Panizo C, Hernandez M, Cuesta B, Rocha E, Bendandi M.
    Haematologica; 2003 Dec; 88(12):1438-40. PubMed ID: 14688006
    [No Abstract] [Full Text] [Related]

  • 3. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
    Bertinetti C, Zirlik K, Heining-Mikesch K, Ihorst G, Dierbach H, Waller CF, Veelken H.
    Cancer Res; 2006 Apr 15; 66(8):4496-502. PubMed ID: 16618777
    [Abstract] [Full Text] [Related]

  • 4. The role of idiotype vaccines in the treatment of human B-cell malignancies.
    Bendandi M.
    Expert Rev Vaccines; 2004 Apr 15; 3(2):163-70. PubMed ID: 15056042
    [Abstract] [Full Text] [Related]

  • 5. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.
    Bertinetti C, Simon F, Zirlik K, Heining-Mikesch K, Pfeifer D, Osterroth F, Rosenthal FM, Veelken H.
    Eur J Haematol; 2006 Nov 15; 77(5):395-402. PubMed ID: 16879605
    [Abstract] [Full Text] [Related]

  • 6. Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies.
    Zabalegui N, de Cerio AL, Inogés S, Rodríguez-Calvillo M, Pérez-Calvo J, Hernández M, García-Foncillas J, Martín-Algarra S, Rocha E, Bendandi M.
    Haematologica; 2004 May 15; 89(5):541-6. PubMed ID: 15136216
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype.
    Weng WK, Czerwinski D, Timmerman J, Hsu FJ, Levy R.
    J Clin Oncol; 2004 Dec 01; 22(23):4717-24. PubMed ID: 15483014
    [Abstract] [Full Text] [Related]

  • 8. BiovaxID®: a customized idiotype vaccine for the treatment of B-cell lymphoma.
    Villanueva H, de Cerio AL, Inoges S, Pastor F, Soldevilla MM, Bendandi M.
    Expert Rev Vaccines; 2011 Dec 01; 10(12):1661-9. PubMed ID: 22085168
    [Abstract] [Full Text] [Related]

  • 9. Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma.
    Inogès S, Rodrìguez-Calvillo M, Zabalegui N, Lòpez-Dìaz de Cerio A, Villanueva H, Soria E, Suárez L, Rodríguez-Caballero A, Pastor F, García-Muñóz R, Panizo C, Pèrez-Calvo J, Melero I, Rocha E, Orfao A, Bendandi M, Grupo Español de Linfomas/Trasplante Autologo de Medula Oseo study group, Programa para el Estudio y Tratamiento de Hemopatias Malignas study group.
    J Natl Cancer Inst; 2006 Sep 20; 98(18):1292-301. PubMed ID: 16985248
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW.
    Expert Rev Vaccines; 2006 Jun 20; 5(3):381-94. PubMed ID: 16827622
    [Abstract] [Full Text] [Related]

  • 11. Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.
    Neelapu SS, Baskar S, Gause BL, Kobrin CB, Watson TM, Frye AR, Pennington R, Harvey L, Jaffe ES, Robb RJ, Popescu MC, Kwak LW.
    Clin Cancer Res; 2004 Dec 15; 10(24):8309-17. PubMed ID: 15623607
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody].
    Kon S.
    Gan To Kagaku Ryoho; 1988 May 15; 15(5):1685-92. PubMed ID: 3259417
    [Abstract] [Full Text] [Related]

  • 13. Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study.
    Yáñez R, Barrios Y, Ruiz E, Cabrera R, Díaz-Espada F.
    J Immunother; 2008 Apr 15; 31(3):310-2. PubMed ID: 18317357
    [Abstract] [Full Text] [Related]

  • 14. Idiotype vaccine strategies for treatment of follicular lymphoma.
    Mahaseth H, Brody JD, Sinha R, Shenoy PJ, Flowers CR.
    Future Oncol; 2011 Jan 15; 7(1):111-22. PubMed ID: 21174542
    [Abstract] [Full Text] [Related]

  • 15. The use of idiotype as a target for clinical immunotherapy of B cell malignancies.
    Kim SB, Kwak LW.
    Cancer Chemother Biol Response Modif; 2001 Jan 15; 19():289-95. PubMed ID: 11686018
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of B-cell lymphoma using peptides. A novel concept.
    Lam KS.
    West J Med; 1993 May 15; 158(5):475-9. PubMed ID: 8342262
    [Abstract] [Full Text] [Related]

  • 17. Idiotype vaccination in follicular lymphoma: knocking on the doorway to cure.
    Longo DL.
    J Natl Cancer Inst; 2006 Sep 20; 98(18):1263-5. PubMed ID: 16985240
    [No Abstract] [Full Text] [Related]

  • 18. [Past, present and future of anti-idiotype vaccination].
    Rodríguez Calvillo M, Inogés S, López Díaz de Cerio A, Zabalegui N, Panizo C, Hernández M, Pérez Calvo J, Prósper F, Melero I, Sánchez-Ibarrola A, Rocha E, Bendandi M.
    Rev Med Univ Navarra; 2004 Sep 20; 48(3):14-23. PubMed ID: 15622921
    [Abstract] [Full Text] [Related]

  • 19. Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system.
    Yang J, Kanter G, Voloshin A, Michel-Reydellet N, Velkeen H, Levy R, Swartz JR.
    Biotechnol Bioeng; 2005 Mar 05; 89(5):503-11. PubMed ID: 15669088
    [Abstract] [Full Text] [Related]

  • 20. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients.
    Timmerman JM, Czerwinski DK, Davis TA, Hsu FJ, Benike C, Hao ZM, Taidi B, Rajapaksa R, Caspar CB, Okada CY, van Beckhoven A, Liles TM, Engleman EG, Levy R.
    Blood; 2002 Mar 01; 99(5):1517-26. PubMed ID: 11861263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.